Shanghai Fosun Pharmaceutical Group Co Ltd

Price Chart

Risk-Adjusted Performance

Also Listed On

Shanghai Fosun Pharmaceutical Group Co Ltd (2196) Price Performance

Shanghai Fosun Pharmaceutical Group Co Ltd (2196) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD18.23, down 2.15% from the previous close.

Over the past year, 2196 has traded between a low of HKD12.89 and a high of HKD28.80. The stock has gained 24.7% over this period. It is currently 36.7% below its 52-week high.

Shanghai Fosun Pharmaceutical Group Co Ltd has a market capitalization of $77.24B, with a price-to-earnings ratio of 13.70 and a dividend yield of 1.66%.

About Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory health and professional medical products; oncology, neuroscience and other specialty fields; and solutions for infections, tumors, the central nervous system, and chronic diseases. In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and special commodities; specialized medical disciplines; and insurance services. Further, it is involved in the import and export of medical equipment and the provision of related and other consulting services and investment management. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.